Alerts will be sent to your verified email
Verify Email
PHRMASI
|
Phaarmasia
|
Onyx Biotec
|
Vivo Bio Tech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-9.08 % | 13.47 % | 7.43 % |
|
5yr average Equity Multiplier
|
2.3 | 2.51 | 2.24 |
|
5yr Average Asset Turnover Ratio
|
0.96 | 0.82 | 0.43 |
|
5yr Avg Net Profit Margin
|
-4.04 % | 6.72 % | 8.3 % |
|
Price to Book
|
5.96 | 1.13 | 0.68 |
|
P/E
|
82.64 | 12.81 | 16.02 |
|
5yr Avg Cash Conversion Cycle
|
-236.72 Days | 36.81 Days | 90.56 Days |
|
Inventory Days
|
79.69 Days | 48.71 Days | 72.05 Days |
|
Days Receivable
|
83.55 Days | 104.89 Days | 90.11 Days |
|
Days Payable
|
340.86 Days | 101.26 Days | 88.09 Days |
|
5yr Average Interest Coverage Ratio
|
-92.68 | 4.89 | 2.13 |
|
5yr Avg ROCE
|
-8.87 % | 12.63 % | 13.85 % |
|
5yr Avg Operating Profit Margin
|
-5.39 % | 14.14 % | 39.67 % |
|
5 yr average Debt to Equity
|
0.0 | 0.95 | 1.08 |
|
5yr CAGR Net Profit
|
n/a | 8.12 % | 5.09 % |
|
5yr Average Return on Assets
|
-3.86 % | 5.64 % | 3.6 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.51 % | 65.1 % | 35.16 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -7.0 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Phaarmasia
|
Onyx Biotec
|
Vivo Bio Tech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|